parthenolide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

parthenolide has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aviles-Vazquez, S; Ayala-Sanchez, M; Chávez-González, A; Crooks, PA; Flores-Lopez, G; Guzman, ML; Mayani, H; Moreno-Lorenzana, D; Torres-Martinez, H	1

Other Studies

1 other study(ies) available for parthenolide and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Article	Year
Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10 Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction	2018

Article

Year

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species.

Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10

Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction

2018